Home
Live Updates
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript : comparemela.com
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript
Operator: Good day ladies and gentlemen and welcome to ACADIA Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. My name is Kathy and I will be your coordinator for today.
Related Keywords
United States ,
Canada ,
Parag Meswani ,
Gregory Renza ,
Brendan Teehan ,
Albert Kildani ,
Yatin Suneja ,
Tessa Romero ,
Mark Schneyer ,
Doug Williamson ,
Kathie Bishop ,
Al Kildani ,
Steve Davis ,
Health Canada ,
Pharmaceuticals Third Quarter ,
Rett Community ,
Acadia Pharmaceuticals Inc ,
Neuron Pharmaceuticals ,
Head Of Research ,
Nasdaq ,
Corporate Communications ,
Call Transcript November ,
Third Quarter ,
Results Conference ,
Senior Vice President ,
Investor Relations ,
Chief Executive Officer ,
Chief Operating Officer ,
Chief Financial Officer ,
Rare Diseases ,
External Innovation ,
Rare Diseases Franchise ,
Private Securities Litigation Reform Act ,
Rett Awareness ,
Inflation Reduction Act ,
Diverse Countries ,
Dangerous Gangs ,
Ritu Baral ,
comparemela.com © 2020. All Rights Reserved.